Flexion Therapeutics Inc. (FLXN)

13.13
0.63 5.04
NASDAQ : Health Technology
Prev Close 12.50
Open 12.56
Day Low/High 12.55 / 13.18
52 Wk Low/High 9.65 / 29.10
Volume 389.90K
Avg Volume 665.20K
Exchange NASDAQ
Shares Outstanding 37.99M
Market Cap 475.67M
EPS -4.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Trading Notes for Select Stocks

Trading Notes for Select Stocks

Here's my take on a list of stocks I've been watching.

2 Small Biotech Stocks That Insiders Are Buying

2 Small Biotech Stocks That Insiders Are Buying

Both names looked poised to go higher as soon as sentiment around the small biotech sector improves.

3 Small Biotechs That Came Up Big on Thursday

3 Small Biotechs That Came Up Big on Thursday

Portola Pharmaceuticals, Flexion Therapeutics and BioDelivery Sciences delivered nice third-quarter numbers.

Netflix Is Tonight's Big Report: Here's How I Would Play It

Netflix Is Tonight's Big Report: Here's How I Would Play It

This is a battleground stock that has made big moves in both directions on earnings in the past.

Square Continues to See Extreme Pressure

Square Continues to See Extreme Pressure

If you are interested in Square longer term be patient and wait for the drama to end.

Biotechs: Adding to Radius Health, Flexion

Biotechs: Adding to Radius Health, Flexion

This downward action in the small biotech sector tends to happen often in the 'dog days' of summer.

A Rash of Biotech News

The April Jobs report showed that 164,000 jobs were created last month. This is nearly 30,000 jobs less than the consensus. Unemployment rates tumbles to 3.9%, the first time under the 4% level in almost two decades. A rash of biotech news hitting t...

Consider These Tier 3 Biotechs

Consider These Tier 3 Biotechs

I hope we get a decent size market decline so I can add to some stakes in what I think are already undervalued biotech holdings.

How Trading Notes Can Increase Your Profits

How Trading Notes Can Increase Your Profits

Inertia is your biggest enemy in this market.

You Can't Reason With a Steamroller

You Can't Reason With a Steamroller

The momentum is crushing everything in its way.

Market Strength Is Putting Bids Under Everything

Market Strength Is Putting Bids Under Everything

The indices are hitting highs as the market shrugs off yesterday's rotation.

Twitter's Stock Isn't Only One to Nibble on Post-Thanksgiving

Twitter's Stock Isn't Only One to Nibble on Post-Thanksgiving

I'm looking for some new entries in less-speculative names, but many stocks need a rest at this point.

The Art and Science of Buying Dips

The Art and Science of Buying Dips

This can produce big gains, but what if the stock keeps dipping?

Stocks on My Radar on This Selling

Stocks on My Radar on This Selling

I'm always excited about the potential for new trades when we have selling like this.

Housing Stocks Will See Demand Boost

Housing Stocks Will See Demand Boost

The housing market will continue to improve over the next few years due to pent up demand.

Don't Panic About Biotech

Don't Panic About Biotech

Diversification is absolutely critical when investing in this sector.

Playing Biotech After FDA Approval

Playing Biotech After FDA Approval

Small biotech stocks have a number of hurdles around FDA approval. Here is how to play that cycle.

Why Is Flexion Falling, and Other Questions

Why Is Flexion Falling, and Other Questions

The first part of Flexion's decline can be attributed to some profit taking.

Flexion Shares Lower After Proposed Stock Offering -- Biotech Movers

Flexion Shares Lower After Proposed Stock Offering -- Biotech Movers

The Burlington, Mass.-based firm announced a proposed public offering of 4 million shares. It plans to use part of the net proceeds to fund manufacturing and commercialization of osteoarthritis knee pain treatment Zilretta.

Flexion Shares Continue Rise After FDA Approval -- Biotech Movers

Flexion Shares Continue Rise After FDA Approval -- Biotech Movers

Burlington, Mass.-based Flexion Therapeutics said Friday it has receive FDA approval for osteoarthritis knee pain treatment Zilretta, a non-opioid medicine utilizing Flexion's microsphere technology.

Paratek Shares Higher on Microbiology Data -- Biotech Movers

Paratek Shares Higher on Microbiology Data -- Biotech Movers

The Boston firm said microbiology data show that investigational antibiotic omadacycline is 'active against the clinically important typical and atypical community-acquired bacterial pneumonia (CABP) pathogens.'

3 Small Biotech Stocks Insiders Are Buying

3 Small Biotech Stocks Insiders Are Buying

Verastem Inc., Pieris Pharmaceuticals and Intra-Cellular Therapies all have promising products.

These 4 Small Biotechs Have Big Upcoming Catalysts

These 4 Small Biotechs Have Big Upcoming Catalysts

Zogenix, Flexion, Dynavax and Progenics all have potential upside on these events.

4 Small Biotechs With Big Catalysts

4 Small Biotechs With Big Catalysts

Zogenix, Flexion, Dynavax and Progenics all have potential upside on upcoming events.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

'Date' These Potential Biotech Winners

'Date' These Potential Biotech Winners

As with Adamas Pharmaceuticals, circling key milestone dates on your calendar can prove beneficial.

2 Biotechs That Could Flex Their Muscles

2 Biotechs That Could Flex Their Muscles

Flexion Therapeutics and Adamis Pharmaceuticals are names to like at current levels.

2 Recovering Biotech Names With Room to Run

2 Recovering Biotech Names With Room to Run

There are reasons to believe rallies in BioDelivery Sciences and Flexion Therapeutics should continue.